133 related articles for article (PubMed ID: 11277780)
1. Potent integrin antagonists from a small library of RGD-including cyclic pseudopeptides.
Belvisi L; Bernardi A; Checchia A; Manzoni L; Potenza D; Scolastico C; Castorina M; Cupelli A; Giannini G; Carminati P; Pisano C
Org Lett; 2001 Apr; 3(7):1001-4. PubMed ID: 11277780
[TBL] [Abstract][Full Text] [Related]
2. Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids.
Belvisi L; Bernardi A; Colombo M; Manzoni L; Potenza D; Scolastico C; Giannini G; Marcellini M; Riccioni T; Castorina M; LoGiudice P; Pisano C
Bioorg Med Chem; 2006 Jan; 14(1):169-80. PubMed ID: 16214345
[TBL] [Abstract][Full Text] [Related]
3. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins.
Koivunen E; Wang B; Ruoslahti E
Biotechnology (N Y); 1995 Mar; 13(3):265-70. PubMed ID: 9634769
[TBL] [Abstract][Full Text] [Related]
4. Photochemical rearrangement of oxaziridines and nitrones in the hexahydroindole series: a convenient synthetic route to 1-azabicyclo[5.2.0]nonan-2-ones as novel RGD mimetics.
Bourguet E; Baneres JL; Girard JP; Parello J; Vidal JP; Lusinchi X; Declercq JP
Org Lett; 2001 Oct; 3(20):3067-70. PubMed ID: 11573996
[TBL] [Abstract][Full Text] [Related]
5. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K
Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of a novel, high affinity and selective αvβ6 integrin RGD-mimetic radioligand.
Hall ER; Bibby LI; Slack RJ
Biochem Pharmacol; 2016 Oct; 117():88-96. PubMed ID: 27501918
[TBL] [Abstract][Full Text] [Related]
7. Nonpeptide RGD antagonists: a novel class of mimetics, the 5,8-disubstituted 1-azabicyclo[5.2.0]nonan-2-one lactam.
Bourguet E; Banères JL; Parello J; Lusinchi X; Girard JP; Vidal JP
Bioorg Med Chem Lett; 2003 May; 13(9):1561-4. PubMed ID: 12699755
[TBL] [Abstract][Full Text] [Related]
8. Conformations and pharmacophores of cyclic RGD containing peptides which selectively bind integrin alpha(v)beta3.
Locardi E; Mullen DG; Mattern RH; Goodman M
J Pept Sci; 1999 Nov; 5(11):491-506. PubMed ID: 10587313
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase synthesis of a nonpeptide RGD mimetic library: new selective alphavbeta3 integrin antagonists.
Sulyok GA; Gibson C; Goodman SL; Hölzemann G; Wiesner M; Kessler H
J Med Chem; 2001 Jun; 44(12):1938-50. PubMed ID: 11384239
[TBL] [Abstract][Full Text] [Related]
10. Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior.
Del Gatto A; Zaccaro L; Grieco P; Novellino E; Zannetti A; Del Vecchio S; Iommelli F; Salvatore M; Pedone C; Saviano M
J Med Chem; 2006 Jun; 49(11):3416-20. PubMed ID: 16722662
[TBL] [Abstract][Full Text] [Related]
11. Two comparisons of the performance of positional scanning and deletion synthesis for the identification of active constituents in mixture combinatorial libraries.
Boger DL; Lee JK; Goldberg J; Jin Q
J Org Chem; 2000 Mar; 65(5):1467-74. PubMed ID: 10814111
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship of potent bicyclic lactam thrombin inhibitors.
Bachand B; DiMaio J; Siddiqui MA
Bioorg Med Chem Lett; 1999 Apr; 9(7):913-8. PubMed ID: 10230610
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
[TBL] [Abstract][Full Text] [Related]
14. RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirements.
Peyman A; Wehner V; Knolle J; Stilz HU; Breipohl G; Scheunemann KH; Carniato D; Ruxer JM; Gourvest JF; Gadek TR; Bodary S
Bioorg Med Chem Lett; 2000 Jan; 10(2):179-82. PubMed ID: 10673106
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.
Meissner RS; Perkins JJ; Duong LT; Hartman GD; Hoffman WF; Huff JR; Ihle NC; Leu CT; Nagy RM; Naylor-Olsen A; Rodan GA; Rodan SB; Whitman DB; Wesolowski GA; Duggan ME
Bioorg Med Chem Lett; 2002 Jan; 12(1):25-9. PubMed ID: 11738566
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold.
Williams R; Manka JT; Rodriguez AL; Vinson PN; Niswender CM; Weaver CD; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
Bioorg Med Chem Lett; 2011 Mar; 21(5):1350-3. PubMed ID: 21315585
[TBL] [Abstract][Full Text] [Related]
17. High-Affinity α
Bernhagen D; Jungbluth V; Gisbert Quilis N; Dostalek J; White PB; Jalink K; Timmerman P
ACS Comb Sci; 2019 Aug; 21(8):598-607. PubMed ID: 31269394
[TBL] [Abstract][Full Text] [Related]
18. Single-step formation of structurally defined bicyclic peptides via S(N)Ar cyclization.
Kohn WD; Zhang L; Weigel JA
Org Lett; 2001 Apr; 3(7):971-4. PubMed ID: 11277772
[TBL] [Abstract][Full Text] [Related]
19. Chloramine T-induced structural and biochemical changes in echistatin.
Kumar CC; Nie H; Armstrong L; Zhang R; Vijay-Kumar S; Tsarbopoulos A
FEBS Lett; 1998 Jun; 429(3):239-48. PubMed ID: 9662425
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial synthesis of RGD model cyclic peptides utilizing a palladium-catalyzed carbonylative macrolactamization on a polymer support.
Kamioka S; Shimazu S; Doi T; Takahashi T
J Comb Chem; 2008; 10(5):681-90. PubMed ID: 18683986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
